-- Auro Laboratories (BOM:530233) received an Attestation of Inspection from the European Directorate for the Quality of Medicines and Healthcare (EDQM) for its Metformin Hydrochloride CEP dossier, according to a Tuesday filing on BSE.
Shares of the company rose nearly 4% in Wednesdays trade.
The certification confirms compliance with Good Manufacturing Practice (GMP) requirements under EU rules for its MIDC Tarapur facility, the filing said.
Zhuhai Rundu Pharmaceutical (SHE:002923) obtained approval from China's National Medical Products Administration for the marketing of losartan potassium, according to a Shenzhen bourse filing on Wednesday.The drug is used for the treatment of primary hypertension and chronic heart failure.The pharmaceutical company's shares rose by less than 2% at the close.
Britain's private sector output growth increased in April, indicating a moderate rise in manufacturing production and in services sector activity, data from S&P Global showed.The seasonally adjusted S&P Global UK PMI Composite Output Index rose to 52.6 from 50.3 in March, according to final data published Wednesday. The flash estimate stood at 52.Meanwhile, the services PMI came in at 52.7, compared with the previous month's 50.5 and the preliminary reading of 52.
Versigent (VGNT) reported Q1 net income Tuesday of $81 million, down from $96 million a year earlier.Net sales for the quarter ended March 31 were $2.21 billion, up from $2.02 billion a year earlier.Analysts surveyed by FactSet expected $2.09 billion.The company said it expects 2026 revenue of $9.10 billion to $9.40 billion. Analysts surveyed by FactSet expect $9.25 billion.Shares of the company traded more than 5% higher in recent premarket activity Wednesday.Price: $39.39, Change: $+1.89, Percent Change: +5.04%